Literature DB >> 22899664

Exception point applications for 15 points: an unintended consequence of the share 15 policy.

Therese Bittermann1, George Makar, David Goldberg.   

Abstract

In 2005, the United Network for Organ Sharing (UNOS) adopted the Share 15 policy to improve organ allocation by facilitating transplantation for local and regional patients with Model for End-Stage Liver Disease (MELD) scores of 15 or higher. There has been concern that the lack of standardization in the use of exception points is potentially diminishing the benefits of this policy. We reviewed all applications for 15 exception points submitted through UNOS from January 1, 2005 through March 14, 2011 (notably, there were only 5 applications for 15 MELD exception points submitted before the initiation of the Share 15 policy). Four hundred fifty-two applications were submitted for 301 patients. There was significant regional variability, with regions 3 and 10 submitting 72.1% of all applications. More than one-quarter of the applications (32.7%) specifically requested exception points to make a patient eligible for a local, regional, or higher risk organ. All applications were accepted for 74.1% of the patients, and 72.2% of these patients ultimately underwent transplantation; however, when all applications were denied, only 54.0% underwent transplantation (P = 0.006). Overall, 197 applicants (65.4%) underwent transplantation with a deceased donor organ, and 80.2% of these patients had a native MELD score at transplantation less than 15. In conclusion, these analyses demonstrate several important changes in practice that have occurred as a result of the implementation of the Share 15 policy. Since 2005, there has been a marked increase in the number of applications for 15 exception points, with significant regional variability in their use and a lack of standardization in their approval.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22899664      PMCID: PMC3484239          DOI: 10.1002/lt.23537

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  11 in total

1.  Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era.

Authors:  David Goldberg; Benjamin French; Arwin Thomasson; K Rajender Reddy; Scott D Halpern
Journal:  Liver Transpl       Date:  2011-11       Impact factor: 5.799

2.  Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.

Authors:  Richard B Freeman; Robert G Gish; Ann Harper; Gary L Davis; John Vierling; Leslie Lieblein; Goran Klintmalm; Jamie Blazek; Robert Hunter; Jeffrey Punch
Journal:  Liver Transpl       Date:  2006-12       Impact factor: 5.799

3.  MELD Exceptions and Rates of Waiting List Outcomes.

Authors:  A B Massie; B Caffo; S E Gentry; E C Hall; D A Axelrod; K L Lentine; M A Schnitzler; A Gheorghian; P R Salvalaggio; D L Segev
Journal:  Am J Transplant       Date:  2011-09-15       Impact factor: 8.086

4.  Liver transplantation in the United States, 1999-2008.

Authors:  P J Thuluvath; M K Guidinger; J J Fung; L B Johnson; S C Rayhill; S J Pelletier
Journal:  Am J Transplant       Date:  2010-04       Impact factor: 8.086

5.  Racial disparities in pediatric access to kidney transplantation: does socioeconomic status play a role?

Authors:  R E Patzer; S Amaral; M Klein; N Kutner; J P Perryman; J A Gazmararian; W M McClellan
Journal:  Am J Transplant       Date:  2012-01-06       Impact factor: 8.086

6.  Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation.

Authors:  Gabriele I Kirchner; Kinan Rifai; Tobias Cantz; Bjoern Nashan; Christoph Terkamp; Thomas Becker; Christian Strassburg; Hannelore Barg-Hock; Siegfried Wagner; Rainer Lück; Juergen Klempnauer; Michael P Manns
Journal:  Liver Transpl       Date:  2006-08       Impact factor: 5.799

7.  The survival benefit of liver transplantation.

Authors:  Robert M Merion; Douglas E Schaubel; Dawn M Dykstra; Richard B Freeman; Friedrich K Port; Robert A Wolfe
Journal:  Am J Transplant       Date:  2005-02       Impact factor: 8.086

8.  Characteristics associated with liver graft failure: the concept of a donor risk index.

Authors:  S Feng; N P Goodrich; J L Bragg-Gresham; D M Dykstra; J D Punch; M A DebRoy; S M Greenstein; R M Merion
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

9.  Hyponatremia and mortality among patients on the liver-transplant waiting list.

Authors:  W Ray Kim; Scott W Biggins; Walter K Kremers; Russell H Wiesner; Patrick S Kamath; Joanne T Benson; Erick Edwards; Terry M Therneau
Journal:  N Engl J Med       Date:  2008-09-04       Impact factor: 91.245

10.  Model for end-stage liver disease (MELD) and allocation of donor livers.

Authors:  Russell Wiesner; Erick Edwards; Richard Freeman; Ann Harper; Ray Kim; Patrick Kamath; Walter Kremers; John Lake; Todd Howard; Robert M Merion; Robert A Wolfe; Ruud Krom
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

View more
  7 in total

1.  Same policy, different impact: Center-level effects of share 35 liver allocation.

Authors:  Douglas R Murken; Allison W Peng; David D Aufhauser; Peter L Abt; David S Goldberg; Matthew H Levine
Journal:  Liver Transpl       Date:  2017-06       Impact factor: 5.799

2.  Model for end-stage liver disease-based organ allocation: managing the exceptions to the rules.

Authors:  David S Goldberg; Michael B Fallon
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-14       Impact factor: 11.382

3.  Current Status of Liver Allocation in the United States.

Authors:  Saleh Elwir; John Lake
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-03

4.  Standardizing MELD Exceptions: Current Challenges and Future Directions.

Authors:  David S Goldberg; Kim M Olthoff
Journal:  Curr Transplant Rep       Date:  2014-12-01

5.  Early changes in liver distribution following implementation of Share 35.

Authors:  A B Massie; E K H Chow; C E Wickliffe; X Luo; S E Gentry; D C Mulligan; D L Segev
Journal:  Am J Transplant       Date:  2015-03       Impact factor: 8.086

6.  Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans.

Authors:  David S Goldberg; Benjamin French; Kimberly A Forde; Peter W Groeneveld; Therese Bittermann; Lisa Backus; Scott D Halpern; David E Kaplan
Journal:  JAMA       Date:  2014-03-26       Impact factor: 56.272

7.  Low Health Literacy Is Associated With Frailty and Reduced Likelihood of Liver Transplant Listing: A Prospective Cohort Study.

Authors:  Therese Bittermann; Kristen Dwinnells; Sakshum Chadha; Michael S Wolf; Kim M Olthoff; Marina Serper
Journal:  Liver Transpl       Date:  2020-10-07       Impact factor: 5.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.